Clinical Trial Update: Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating GSK3845097 in previously treated patients with advanced synovial sarcoma and myxoid/round cell liposarcoma was terminated, and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myxoid Round Cell Liposarcoma
• Synovial Sarcoma

Drugs mentioned

• GSK3845097

Snippet

Sponsor: Adaptimmune | Conditions: Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2024-03-18